author-photo

Jennifer Schreiber

9

Papers

60

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Data for: PARP inhibition blocks alcohol-induced neurodegeneration and neuroinflammatory cytosolic phospholipase A2 elevations

2019 Neurochemistry International
Show All
- Source
- Cite
- Save
Citations (0)
Universal Design for Learning: A Student-Centered Curriculum Perspective.

2017 Curriculum and teaching
- Jennifer Schreiber
Show All
- Source
- Cite
- Save
Citations (2)
First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors.

2015 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (31)
Phase 2 Study of Carfilzomib (CFZ) with or without Filanesib (FIL) in Patients with Advanced Multiple Myeloma (MM)

2015 Blood
Show All
- Source
- Cite
- Save
Citations (8)
Impedance-Assisted Amperometry and Voltammetry for Biological Applications

2013
- Jennifer Schreiber
- Baur, Faculty Advisor, Melinda
Show All
- Source
- Cite
- Save
Citations (0)
Abstract A252: A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers.

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (18)
SCANNING ELECTROCHEMICAL MICROSCOPY MAPPING OF NEUROTRANSMITTER RELEASE SITES FROM MODEL NEURONS

2012
- Jennifer Schreiber
- Baur, Faculty Advisor, Melinda
Show All
- Source
- Cite
- Save
Citations (0)